Exploring Immunome and Microbiome Interplay in Reproductive Health: Current Knowledge, Challenges, and Novel Diagnostic Tools

Prakash Lingasamy; Vijayachitra Modhukur; Reet Mändar; Andres Salumets

doi:10.1055/s-0043-1778017

Seminars in Reproductive Medicine, Table of Contents

CC BY-NC-ND 4.0 · Semin Reprod Med 2023; 41(05): 172-189
DOI: 10.1055/s-0043-1778017

Review Article

Exploring Immunome and Microbiome Interplay in Reproductive Health: Current Knowledge, Challenges, and Novel Diagnostic Tools

Prakash Lingasamy

¹Competence Centre on Health Technologies, Tartu, Estonia

,

Vijayachitra Modhukur

¹Competence Centre on Health Technologies, Tartu, Estonia

²Department of Obstetrics and Gynecology, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia

,

Reet Mändar

¹Competence Centre on Health Technologies, Tartu, Estonia

³Department of Microbiology, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia

,

Andres Salumets

¹Competence Centre on Health Technologies, Tartu, Estonia

²Department of Obstetrics and Gynecology, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia

⁴Division of Obstetrics and Gynecology, Department of Clinical Science, Intervention and Technology, Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden

› Author Affiliations

Abstract

The dynamic interplay between the immunome and microbiome in reproductive health is a complex and rapidly advancing research field, holding tremendously vast possibilities for the development of reproductive medicine. This immunome–microbiome relationship influences the innate and adaptive immune responses, thereby affecting the onset and progression of reproductive disorders. However, the mechanisms governing these interactions remain elusive and require innovative approaches to gather more understanding. This comprehensive review examines the current knowledge on reproductive microbiomes across various parts of female reproductive tract, with special consideration of bidirectional interactions between microbiomes and the immune system. Additionally, it explores innate and adaptive immunity, focusing on immunoglobulin (Ig) A and IgM antibodies, their regulation, self-antigen tolerance mechanisms, and their roles in immune homeostasis. This review also highlights ongoing technological innovations in microbiota research, emphasizing the need for standardized detection and analysis methods. For instance, we evaluate the clinical utility of innovative technologies such as Phage ImmunoPrecipitation Sequencing (PhIP-Seq) and Microbial Flow Cytometry coupled to Next-Generation Sequencing (mFLOW-Seq). Despite ongoing advancements, we emphasize the need for further exploration in this field, as a deeper understanding of immunome–microbiome interactions holds promise for innovative diagnostic and therapeutic strategies for reproductive health, like infertility treatment and management of pregnancy.

Keywords

immunome - microbiome - reproductive health - phage immunoprecipitation sequencing - microbial flow cytometry - next-generation sequencing - diagnostic tools - therapeutic interventions - interactions

Full Text

References

References
1 Wang B, Yao M, Lv L, Ling Z, Li L. The human microbiota in health and disease. Engineering 2017; 3 (01) 71-82
2 Sender R, Fuchs S, Milo R. Revised estimates for the number of human and bacteria cells in the body. PLoS Biol 2016; 14 (08) e1002533
3 Brüls T, Weissenbach J. The human metagenome: our other genome?. Hum Mol Genet 2011; 20 (R2): R142-R148
4 Donders GGG, Bellen G, Ruban KS. Abnormal vaginal microbiome is associated with severity of localized provoked vulvodynia. Role of aerobic vaginitis and Candida in the pathogenesis of vulvodynia. Eur J Clin Microbiol Infect Dis 2018; 37 (09) 1679-1685
5 Onderdonk AB, Delaney ML, Fichorova RN. The human microbiome during bacterial vaginosis. Clin Microbiol Rev 2016; 29 (02) 223-238
6 Sobel JD. Bacterial vaginosis. Annu Rev Med 2000; 51 (01) 349-356
7 Huttenhower C, Gevers D, Knight R. et al; Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature 2012; 486 (7402) 207-214
8 Wang N, Chen L, Yi K, Zhang B, Li C, Zhou X. The effects of microbiota on reproductive health: a review. Crit Rev Food Sci Nutr 2022; 1-22
9 Chen C, Song X, Wei W. et al. The microbiota continuum along the female reproductive tract and its relation to uterine-related diseases. Nat Commun 2017; 8 (01) 875
10 Rowe M, Veerus L, Trosvik P, Buckling A, Pizzari T. The reproductive microbiome: an emerging driver of sexual selection, sexual conflict, mating systems, and reproductive isolation. Trends Ecol Evol 2020; 35 (03) 220-234
11 Feng T, Liu Y. Microorganisms in the reproductive system and probiotic's regulatory effects on reproductive health. Comput Struct Biotechnol J 2022; 20: 1541-1553
12 Schoenmakers S, Steegers-Theunissen R, Faas M. The matter of the reproductive microbiome. Obstet Med 2019; 12 (03) 107-115
13 Tomaiuolo R, Veneruso I, Cariati F, D'Argenio V. Microbiota and human reproduction: the case of female infertility. High Throughput 2020; 9 (02) 12
14 Quaranta G, Sanguinetti M, Masucci L. Fecal microbiota transplantation: a potential tool for treatment of human female reproductive tract diseases. Front Immunol 2019; 10: 2653
15 Miles SM, Hardy BL, Merrell DSS. Investigation of the microbiota of the reproductive tract in women undergoing a total hysterectomy and bilateral salpingo-oopherectomy. Fertil Steril 2017; 107 (03) 813-820.e1
16 Moreno I, Simon C. Deciphering the effect of reproductive tract microbiota on human reproduction. Reprod Med Biol 2018; 18 (01) 40-50
17 Bhattacharya K, Dutta S, Sengupta P, Bagchi S. Reproductive tract microbiome and therapeutics of infertility. Middle East Fertil Soc J 2023; 28 (01) 11
18 Garcia-Grau I, Perez-Villaroya D, Bau D. et al. Taxonomical and functional assessment of the endometrial microbiota in a context of recurrent reproductive failure: A case report. Pathogens 2019; 8 (04) 4-6
19 Muraoka A, Suzuki M, Hamaguchi T. et al. Fusobacterium infection facilitates the development of endometriosis through the phenotypic transition of endometrial fibroblasts. Sci Transl Med 2023; 15 (700) eadd1531
20 Payne MS, Newnham JP, Doherty DA. et al. A specific bacterial DNA signature in the vagina of Australian women in midpregnancy predicts high risk of spontaneous preterm birth (the Predict1000 study). Am J Obstet Gynecol 2021; 224 (02) 206.e1-206.e23
21 France MT, Ma B, Gajer P. et al. VALENCIA: a nearest centroid classification method for vaginal microbial communities based on composition. Microbiome 2020; 8 (01) 166
22 Britto AMA, Siqueira JD, Curty G. et al. Microbiome analysis of Brazilian women cervix reveals specific bacterial abundance correlation to RIG-like receptor gene expression. Front Immunol 2023; 14: 1147950
23 Ravel J, Gajer P, Abdo Z. et al. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci U S A 2011; 108 (Suppl 1, Suppl 1): 4680-4687
24 Cocomazzi G, De Stefani S, Del Pup L. et al. The impact of the female genital microbiota on the outcome of assisted reproduction treatments. Microorganisms 2023; 11 (06) 1443
25 Lehtoranta L, Ala-Jaakkola R, Laitila A, Maukonen J. Healthy vaginal microbiota and influence of probiotics across the female life span. Front Microbiol 2022; 13: 819958
26 Mändar R, Punab M, Borovkova N. et al. Complementary seminovaginal microbiome in couples. Res Microbiol 2015; 166 (05) 440-447
27 O'Hanlon DE, Moench TR, Cone RA. Vaginal pH and microbicidal lactic acid when lactobacilli dominate the microbiota. PLoS ONE 2013; 8 (11) e80074
28 Younes JA, Lievens E, Hummelen R, van der Westen R, Reid G, Petrova MI. Women and their microbes: the unexpected friendship. Trends Microbiol 2018; 26 (01) 16-32
29 Delgado-Diaz DJ, Tyssen D, Hayward JA, Gugasyan R, Hearps AC, Tachedjian G. Distinct immune responses elicited from cervicovaginal epithelial cells by lactic acid and short chain fatty acids associated with optimal and non-optimal vaginal microbiota. Front Cell Infect Microbiol 2020; 9: 446
30 Adapen C, Réot L, Menu E. Role of the human vaginal microbiota in the regulation of inflammation and sexually transmitted infection acquisition: contribution of the non-human primate model to a better understanding?. Front Reprod Health 2022; 4: 992176
31 Coleman JS, Gaydos CA. Molecular diagnosis of bacterial vaginosis: an update. J Clin Microbiol 2018; 56 (09)
32 Koort K, Sõsa K, Türk S. et al. Lactobacillus crispatus-dominated vaginal microbiome and Acinetobacter-dominated seminal microbiome support beneficial ART outcome. Acta Obstet Gynecol Scand 2023; 102 (07) 921-934
33 Kumar L, Dwivedi M, Jain N. et al. The female reproductive tract microbiota: friends and foe. Life (Basel) 2023; 13 (06) 1313
34 Ravel J, Moreno I, Simón C. Bacterial vaginosis and its association with infertility, endometritis, and pelvic inflammatory disease. Am J Obstet Gynecol 2021; 224 (03) 251-257
35 Štšepetova J, Baranova J, Simm J. et al. The complex microbiome from native semen to embryo culture environment in human in vitro fertilization procedure. Reprod Biol Endocrinol 2020; 18 (01) 3
36 Yan C, Hong F, Xin G, Duan S, Deng X, Xu Y. Alterations in the vaginal microbiota of patients with preterm premature rupture of membranes. Front Cell Infect Microbiol 2022; 12: 858732
37 Fettweis JM, Serrano MG, Brooks JP. et al. The vaginal microbiome and preterm birth. Nat Med 2019; 25 (06) 1012-1021
38 Nguyen ATC, Le Nguyen NT, Hoang TTA. et al. Aerobic vaginitis in the third trimester and its impact on pregnancy outcomes. BMC Pregnancy Childbirth 2022; 22 (01) 432
39 Barczyński B, Frąszczak K, Grywalska E, Kotarski J, Korona-Głowniak I. Vaginal and cervical microbiota composition in patients with endometrial cancer. Int J Mol Sci 2023; 24 (09) 8266
40 Bednarska-Czerwińska A, Morawiec E, Zmarzły N. et al. Dynamics of microbiome changes in the endometrium and uterine cervix during embryo implantation: a comparative analysis. Med Sci Monit 2023; 29: e941289
41 Dong M, Dong Y, Bai J. et al. Interactions between microbiota and cervical epithelial, immune, and mucus barrier. Front Cell Infect Microbiol 2023; 13 (February): 1124591
42 Liang J, Li M, Zhang L. et al. Analysis of the microbiota composition in the genital tract of infertile patients with chronic endometritis or endometrial polyps. Front Cell Infect Microbiol 2023; 13: 1125640
43 Tuominen H, Rautava S, Syrjänen S, Collado MC, Rautava J. HPV infection and bacterial microbiota in the placenta, uterine cervix and oral mucosa. Sci Rep 2018; 8 (01) 9787
44 Payne MS, Ireland DJ, Watts R. et al. Ureaplasma parvum genotype, combined vaginal colonisation with Candida albicans, and spontaneous preterm birth in an Australian cohort of pregnant women. BMC Pregnancy Childbirth 2016; 16 (01) 312
45 Parnell LA, Briggs CM, Mysorekar IU. Maternal microbiomes in preterm birth: recent progress and analytical pipelines. Semin Perinatol 2017; 41 (07) 392-400
46 Anahtar MN, Gootenberg DB, Mitchell CM, Kwon DS. Cervicovaginal microbiota and reproductive health: the virtue of simplicity. Cell Host Microbe 2018; 23 (02) 159-168
47 Mitchell CM, Haick A, Nkwopara E. et al. Colonization of the upper genital tract by vaginal bacterial species in nonpregnant women. Am J Obstet Gynecol 2015; 212 (05) 611.e1-611.e9
48 Koedooder R, Mackens S, Budding A. et al. Identification and evaluation of the microbiome in the female and male reproductive tracts. Hum Reprod Update 2019; 25 (03) 298-325
49 Moreno I, Codoñer FM, Vilella F. et al. Evidence that the endometrial microbiota has an effect on implantation success or failure. Am J Obstet Gynecol 2016; 215 (06) 684-703
50 Molina NM, Sola-Leyva A, Saez-Lara MJ. et al. New opportunities for endometrial health by modifying uterine microbial composition: present or future?. Biomolecules 2020; 10 (04) 593
51 Molina NM, Sola-Leyva A, Haahr T. et al. Analysing endometrial microbiome: methodological considerations and recommendations for good practice. Hum Reprod 2021; 36 (04) 859-879
52 Sola-Leyva A, Andrés-León E, Molina NM. et al. Mapping the entire functionally active endometrial microbiota. Hum Reprod 2021; 36 (04) 1021-1031
53 Franasiak JM, Werner MD, Juneau CR. et al. Endometrial microbiome at the time of embryo transfer: next-generation sequencing of the 16S ribosomal subunit. J Assist Reprod Genet 2016; 33 (01) 129-136
54 Moreno I, Garcia-Grau I, Perez-Villaroya D. et al. Endometrial microbiota composition is associated with reproductive outcome in infertile patients. Microbiome 2022; 10 (01) 1
55 Diaz-Martínez MDC, Bernabeu A, Lledó B. et al. Impact of the vaginal and endometrial microbiome pattern on assisted reproduction outcomes. J Clin Med 2021; 10 (18) 4063
56 Wee BA, Thomas M, Sweeney EL. et al. A retrospective pilot study to determine whether the reproductive tract microbiota differs between women with a history of infertility and fertile women. Aust N Z J Obstet Gynaecol 2018; 58 (03) 341-348
57 Hiraoka T, Osuga Y, Hirota Y. Current perspectives on endometrial receptivity: A comprehensive overview of etiology and treatment. J Obstet Gynaecol Res 2023; 49 (10) 2397-2409
58 Lüll K, Saare M, Peters M. et al. Differences in microbial profile of endometrial fluid and tissue samples in women with in vitro fertilization failure are driven by Lactobacillus abundance. Acta Obstet Gynecol Scand 2022; 101 (02) 212-220
59 Riganelli L, Iebba V, Piccioni M. et al. Structural variations of vaginal and endometrial microbiota: hints on female infertility. Front Cell Infect Microbiol 2020; 10: 350
60 Ojosnegros S, Seriola A, Godeau AL, Veiga A. Embryo implantation in the laboratory: an update on current techniques. Hum Reprod Update 2021; 27 (03) 501-530
61 Silpe JE, Balskus EP. Deciphering human microbiota-host chemical interactions. ACS Cent Sci 2021; 7 (01) 20-29
62 Belizário JE, Napolitano M. Human microbiomes and their roles in dysbiosis, common diseases, and novel therapeutic approaches. Front Microbiol 2015; 6 (Oct): 1050
63 Purcell RV, Pearson J, Aitchison A, Dixon L, Frizelle FA, Keenan JI. Colonization with enterotoxigenic Bacteroides fragilis is associated with early-stage colorectal neoplasia. PLoS One 2017; 12 (02) e0171602
64 Pelzer ES, Willner D, Buttini M, Hafner LM, Theodoropoulos C, Huygens F. The fallopian tube microbiome: implications for reproductive health. Oncotarget 2018; 9 (30) 21541-21551
65 Peric A, Weiss J, Vulliemoz N, Baud D, Stojanov M. Bacterial colonization of the female upper genital tract. Int J Mol Sci 2019; 20 (14) 3405
66 Canha-Gouveia A, Pérez-Prieto I, Rodríguez CM. et al. The female upper reproductive tract harbors endogenous microbial profiles. Front Endocrinol 2023; 14: 1096050
67 Mondal AS, Sharma R, Trivedi N. Bacterial vaginosis: a state of microbial dysbiosis. Med Microecology 2023; 16: 100082
68 Wasfi R, Abd El-Rahman OA, Zafer MM, Ashour HM. Probiotic Lactobacillus sp. inhibit growth, biofilm formation and gene expression of caries-inducing Streptococcus mutans. J Cell Mol Med 2018; 22 (03) 1972-1983
69 Banerjee S, Tian T, Wei Z. et al. The ovarian cancer oncobiome. Oncotarget 2017; 8 (22) 36225-36245
70 Wang X, Zheng Y, Chen X. et al. 2bRAD-M reveals the difference in microbial distribution between cancerous and benign ovarian tissues. Front Microbiol 2023; 14: 1231354
71 Zhou B, Sun C, Huang J. et al. The biodiversity composition of microbiome in ovarian carcinoma patients. Sci Rep 2019; 9 (01) 1691
72 Païssé S, Valle C, Servant F. et al. Comprehensive description of blood microbiome from healthy donors assessed by 16S targeted metagenomic sequencing. Transfusion 2016; 56 (05) 1138-1147
73 Wang Q, Zhao L, Han L. et al. The differential distribution of bacteria between cancerous and noncancerous ovarian tissues in situ. J Ovarian Res 2020; 13 (01) 8
74 Aagaard K, Ma J, Antony KM, Ganu R, Petrosino J, Versalovic J. The placenta harbors a unique microbiome. Sci Transl Med 2014; 6 (237) 237ra65
75 Kennedy KM, de Goffau MC, Perez-Muñoz ME. et al. Questioning the fetal microbiome illustrates pitfalls of low-biomass microbial studies. Nature 2023; 613 (7945) 639-649
76 Perez-Muñoz ME, Arrieta MC, Ramer-Tait AE, Walter J. A critical assessment of the “sterile womb” and “in utero colonization” hypotheses: implications for research on the pioneer infant microbiome. Microbiome 2017; 5 (01) 48
77 Prince AL, Ma J, Kannan PS. et al. The placental membrane microbiome is altered among subjects with spontaneous preterm birth with and without chorioamnionitis. Am J Obstet Gynecol 2016; 214 (05) 627.e1-627.e16
78 de Goffau MC, Lager S, Sovio U. et al. Human placenta has no microbiome but can contain potential pathogens. Nature 2019; 572 (7769) 329-334
79 Farooqi HMU, Kim KH, Kausar F, Muhammad J, Bukhari H, Choi KH. Frequency and molecular characterization of Staphylococcus aureus from placenta of mothers with term and preterm deliveries. Life (Basel) 2022; 12 (02) 257
80 Kuperman AA, Zimmerman A, Hamadia S. et al. Deep microbial analysis of multiple placentas shows no evidence for a placental microbiome. BJOG 2020; 127 (02) 159-169
81 Parhi L, Abed J, Shhadeh A. et al. Placental colonization by Fusobacterium nucleatum is mediated by binding of the Fap2 lectin to placentally displayed Gal-GalNAc. Cell Rep 2022; 38 (12) 110537
82 Sterpu I, Fransson E, Hugerth LW. et al. No evidence for a placental microbiome in human pregnancies at term. Am J Obstet Gynecol 2021; 224 (03) 296.e1-296.e23
83 Belkaid Y, Hand TW. Role of the microbiota in immunity and inflammation. Cell 2014; 157 (01) 121-141
84 Hou K, Wu ZX, Chen XY. et al. Microbiota in health and diseases. Signal Transduct Target Ther 2022; 7 (01) 135
85 Lee YK, Mazmanian SK. Has the microbiota played a critical role in the evolution of the adaptive immune system?. Science 2010; 330 (6012) 1768-1773
86 Donald K, Petersen C, Turvey SE, Finlay BB, Azad MB. Secretory IgA: linking microbes, maternal health, and infant health through human milk. Cell Host Microbe 2022; 30 (05) 650-659
87 Bonney EA. Immune regulation in pregnancy: a matter of perspective?. Obstet Gynecol Clin North Am 2016; 43 (04) 679-698
88 Al-Nasiry S, Ambrosino E, Schlaepfer M. et al. The interplay between reproductive tract microbiota and immunological system in human reproduction. Front Immunol 2020; 11: 378
89 Gholiof M, Adamson-De Luca E, Wessels JM. The female reproductive tract microbiotas, inflammation, and gynecological conditions. Front Reprod Health 2022; 4: 963752
90 Proctor LM, Creasy HH, Fettweis JM. et al; Integrative HMP (iHMP) Research Network Consortium. The Integrative Human Microbiome Project. Nature 2019; 569 (7758) 641-648
91 Breedveld AC, Schuster HJ, van Houdt R. et al. Enhanced IgA coating of bacteria in women with Lactobacillus crispatus-dominated vaginal microbiota. Microbiome 2022; 10 (01) 15
92 Jin J, Gao L, Zou X. et al. Gut dysbiosis promotes preeclampsia by regulating macrophages and trophoblasts. Circ Res 2022; 131 (06) 492-506
93 Tao Z, Chen Y, He F. et al. Alterations in the gut microbiome and metabolisms in pregnancies with fetal growth restriction. Microbiol Spectr 2023; 11 (03)
94 Hasain Z, Mokhtar NM, Kamaruddin NA. et al. Gut microbiota and gestational diabetes mellitus: a review of host-gut microbiota interactions and their therapeutic potential. Front Cell Infect Microbiol 2020; 10: 188
95 Mitchell C, Marrazzo J. Bacterial vaginosis and the cervicovaginal immune response. Am J Reprod Immunol 2014; 71 (06) 555-563
96 Horne AW, Stock SJ, King AE. Innate immunity and disorders of the female reproductive tract. Reproduction 2008; 135 (06) 739-749
97 Witkin SS, Linhares IM, Giraldo P. Bacterial flora of the female genital tract: function and immune regulation. Best Pract Res Clin Obstet Gynaecol 2007; 21 (03) 347-354
98 Anahtar MN, Byrne EH, Doherty KE. et al. Cervicovaginal bacteria are a major modulator of host inflammatory responses in the female genital tract. Immunity 2015; 42 (05) 965-976
99 Mor G, Aldo P, Alvero AB. The unique immunological and microbial aspects of pregnancy. Nat Rev Immunol 2017; 17 (08) 469-482
100 Nasu K, Narahara H. Pattern recognition via the toll-like receptor system in the human female genital tract. Mediators Inflamm 2010; 2010: 976024
101 Kogut MH, Lee A, Santin E. Microbiome and pathogen interaction with the immune system. Poult Sci 2020; 99 (04) 1906-1913
102 Agostinis C, Mangogna A, Bossi F, Ricci G, Kishore U, Bulla R. Uterine immunity and microbiota: a shifting paradigm. Front Immunol 2019; 10 (OCT): 2387
103 Atay S, Gercel-Taylor C, Suttles J, Mor G, Taylor DD. Trophoblast-derived exosomes mediate monocyte recruitment and differentiation. Am J Reprod Immunol 2011; 65 (01) 65-77
104 Villa P, Cipolla C, D'Ippolito S. et al. The interplay between immune system and microbiota in gynecological diseases: a narrative review. Eur Rev Med Pharmacol Sci 2020; 24 (10) 5676-5690
105 Arnold KB, Burgener A, Birse K. et al. Increased levels of inflammatory cytokines in the female reproductive tract are associated with altered expression of proteases, mucosal barrier proteins, and an influx of HIV-susceptible target cells. Mucosal Immunol 2016; 9 (01) 194-205
106 He Y, Fu L, Li Y. et al. Gut microbial metabolites facilitate anticancer therapy efficacy by modulating cytotoxic CD8⁺ T cell immunity. Cell Metab 2021; 33 (05) 988-1000.e7
107 Carvalho FA, Aitken JD, Vijay-Kumar M, Gewirtz AT. Toll-like receptor-gut microbiota interactions: perturb at your own risk!. Annu Rev Physiol 2012; 74 (01) 177-198
108 Baker JM, Chase DM, Herbst-Kralovetz MM. Uterine microbiota: residents, tourists, or invaders?. Front Immunol 2018; 9 (MAR): 208
109 Maslowski KM, Vieira AT, Ng A. et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 2009; 461 (7268) 1282-1286
110 Ruff WE, Greiling TM, Kriegel MA. Host-microbiota interactions in immune-mediated diseases. Nat Rev Microbiol 2020; 18 (09) 521-538
111 Zheng D, Liwinski T, Elinav E. Interaction between microbiota and immunity in health and disease. Cell Res 2020; 30 (06) 492-506
112 Mu Q, Tavella VJ, Luo XM. Role of Lactobacillus reuteri in human health and diseases. Front Microbiol 2018; 9 (APR): 757
113 Maloy KJ, Powrie F. Regulatory T cells in the control of immune pathology. Nat Immunol 2001; 2 (09) 816-822
114 Ssemaganda A, Cholette F, Perner M. et al. Endocervical regulatory T cells are associated with decreased genital inflammation and lower HIV target cell abundance. Front Immunol 2021; 12: 726472
115 Coombes JL, Siddiqui KRR, Arancibia-Cárcamo CV. et al. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-β and retinoic acid-dependent mechanism. J Exp Med 2007; 204 (08) 1757-1764
116 Duluc D, Gannevat J, Anguiano E. et al. Functional diversity of human vaginal APC subsets in directing T-cell responses. Mucosal Immunol 2013; 6 (03) 626-638
117 Monin L, Whettlock EM, Male V. Immune responses in the human female reproductive tract. Immunology 2020; 160 (02) 106-115
118 Frew L, Stock SJ. Antimicrobial peptides and pregnancy. Reproduction 2011; 141 (06) 725-735
119 Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol 2015; 13 (05) 269-284
120 Sterlin D, Fadlallah J, Slack E, Gorochov G. The antibody/microbiota interface in health and disease. Mucosal Immunol 2020; 13 (01) 3-11
121 Chen K, Magri G, Grasset EK, Cerutti A. Rethinking mucosal antibody responses: IgM, IgG and IgD join IgA. Nat Rev Immunol 2020; 20 (07) 427-441
122 Torcia MG. Interplay among vaginal microbiome, immune response and sexually transmitted viral infections. Int J Mol Sci 2019; 20 (02) 266
123 Bulmer JN, Williams PJ, Lash GE. Immune cells in the placental bed. Int J Dev Biol 2010; 54 (2-3): 281-294
124 Abelius MS, Janefjord C, Ernerudh J. et al. The placental immune milieu is characterized by a Th2- and anti-inflammatory transcription profile, regardless of maternal allergy, and associates with neonatal immunity. Am J Reprod Immunol 2015; 73 (05) 445-459
125 Muzzio DO, Soldati R, Ehrhardt J. et al. B cell development undergoes profound modifications and adaptations during pregnancy in mice. Biol Reprod 2014; 91 (05) 115
126 Lee SK, Kim CJ, Kim DJ, Kang JH. Immune cells in the female reproductive tract. Immune Netw 2015; 15 (01) 16-26
127 Zhang Y, Liu Z, Sun H. Fetal-maternal interactions during pregnancy: a ‘three-in-one’ perspective. Front Immunol 2023; 14: 1198430
128 Ding J, Maxwell A, Adzibolosu N. et al. Mechanisms of immune regulation by the placenta: role of type I interferon and interferon-stimulated genes signaling during pregnancy. Immunol Rev 2022; 308 (01) 9-24
129 Wira CR, Fahey JV, Rodriguez-Garcia M, Shen Z, Patel MV. Regulation of mucosal immunity in the female reproductive tract: the role of sex hormones in immune protection against sexually transmitted pathogens. Am J Reprod Immunol 2014; 72 (02) 236-258
130 Nagamatsu T, Schust DJ. The immunomodulatory roles of macrophages at the maternal-fetal interface. Reprod Sci 2010; 17 (03) 209-218
131 Harding CV, Ramachandra L, Wick MJ. Interaction of bacteria with antigen presenting cells: influences on antigen presentation and antibacterial immunity. Curr Opin Immunol 2003; 15 (01) 112-119
132 Barnea ER, Kirk D, Todorova K, McElhinney J, Hayrabedyan S, Fernández N. PIF direct immune regulation: blocks mitogen-activated PBMCs proliferation, promotes TH2/TH1 bias, independent of Ca(2+). Immunobiology 2015; 220 (07) 865-875
133 Cauci S. Vaginal immunity in bacterial vaginosis. Curr Infect Dis Rep 2004; 6 (06) 450-456
134 Wira CR, Fahey JV, Sentman CL, Pioli PA, Shen L. Innate and adaptive immunity in female genital tract: cellular responses and interactions. Immunol Rev 2005; 206 (01) 306-335
135 Wines BD, Hogarth PM. IgA receptors in health and disease. Tissue Antigens 2006; 68 (02) 103-114
136 Takeuchi T, Ohno H. IgA in human health and diseases: potential regulator of commensal microbiota. Front Immunol 2022; 13: 1024330
137 Breedveld A, van Egmond M. IgA and FcαRI: pathological roles and therapeutic opportunities. Front Immunol 2019; 10 (Mar): 553
138 Macpherson AJ, Yilmaz B, Limenitakis JP, Ganal-Vonarburg SC. IgA function in relation to the intestinal microbiota. Annu Rev Immunol 2018; 36: 359-381
139 Okai S, Usui F, Yokota S. et al. High-affinity monoclonal IgA regulates gut microbiota and prevents colitis in mice. Nat Microbiol 2016; 1 (09) 16103
140 Bunker JJ, Erickson SA, Flynn TM. et al. Natural polyreactive IgA antibodies coat the intestinal microbiota. Science 2017; 358 (6361) eaan6619
141 Sterlin D, Fadlallah J, Adams O. et al. Human IgA binds a diverse array of commensal bacteria. J Exp Med 2020; 217 (03) e20181635
142 Mantis NJ, Rol N, Corthésy B. Secretory IgA's complex roles in immunity and mucosal homeostasis in the gut. Mucosal Immunol 2011; 4 (06) 603-611
143 Catanzaro JR, Strauss JD, Bielecka A. et al. IgA-deficient humans exhibit gut microbiota dysbiosis despite secretion of compensatory IgM. Sci Rep 2019; 9 (01) 13574
144 Fadlallah J, El Kafsi H, Sterlin D. et al. Microbial ecology perturbation in human IgA deficiency. Sci Transl Med 2018; 10 (439) eaan1217
145 Johansen FE, Kaetzel CS. Regulation of the polymeric immunoglobulin receptor and IgA transport: new advances in environmental factors that stimulate pIgR expression and its role in mucosal immunity. Mucosal Immunol 2011; 4 (06) 598-602
146 Ramsland PA, Willoughby N, Trist HM. et al. Structural basis for evasion of IgA immunity by Staphylococcus aureus revealed in the complex of SSL7 with Fc of human IgA1. Proc Natl Acad Sci U S A 2007; 104 (38) 15051-15056
147 Safaeian M, Falk RT, Rodriguez AC. et al. Factors associated with fluctuations in IgA and IgG levels at the cervix during the menstrual cycle. J Infect Dis 2009; 199 (03) 455-463
148 Jones K, Savulescu AF, Brombacher F, Hadebe S. Immunoglobulin M in health and diseases: How far have we come and what next?. Front Immunol 2020; 11: 595535
149 Flajnik MF, Kasahara M. Origin and evolution of the adaptive immune system: genetic events and selective pressures. Nat Rev Genet 2010; 11 (01) 47-59
150 Blandino R, Baumgarth N. Secreted IgM: new tricks for an old molecule. J Leukoc Biol 2019; 106 (05) 1021-1034
151 Litvack ML, Post M, Palaniyar N. IgM promotes the clearance of small particles and apoptotic microparticles by macrophages. PLoS One 2011; 6 (03) e17223
152 Ehrenstein MR, Notley CA. The importance of natural IgM: scavenger, protector and regulator. Nat Rev Immunol 2010; 10 (11) 778-786
153 Racine R, Winslow GM. IgM in microbial infections: taken for granted?. Immunol Lett 2009; 125 (02) 79-85
154 Grönwall C, Vas J, Silverman GJ. Protective roles of natural IgM antibodies. Front Immunol 2012; 3 (Apr): 66
155 Cooper NR, Nemerow GR, Mayes JT. Methods to detect and quantitate complement activation. Springer Semin Immunopathol 1983; 6 (2-3): 195-212
156 Gupta S, Gupta A. Selective IgM deficiency-an underestimated primary immunodeficiency. Front Immunol 2017; 8 (SEP): 1056
157 Magri G, Comerma L, Pybus M. et al. Human secretory IgM emerges from plasma cells clonally related to gut memory b cells and targets highly diverse commensals. Immunity 2017; 47 (01) 118-134.e8
158 Macpherson AJ, Gatto D, Sainsbury E, Harriman GR, Hengartner H, Zinkernagel RM. A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria. Science 2000; 288 (5474) 2222-2226
159 Li Y, Shen H, Zhang R. et al. Immunoglobulin M perception by FcμR. Nature 2023; 615 (7954) 907-912
160 Shibuya A, Sakamoto N, Shimizu Y. et al. Fc α/μ receptor mediates endocytosis of IgM-coated microbes. Nat Immunol 2000; 1 (05) 441-446
161 Devito C, Ellegård R, Falkeborn T. et al. Human IgM monoclonal antibodies block HIV-transmission to immune cells in cervico-vaginal tissues and across polarized epithelial cells in vitro. Sci Rep 2018; 8 (01) 10180
162 Kirkland D, Benson A, Mirpuri J. et al. B cell-intrinsic MyD88 signaling prevents the lethal dissemination of commensal bacteria during colonic damage. Immunity 2012; 36 (02) 228-238
163 Devito C, Broliden K, Kaul R. et al. Mucosal and plasma IgA from HIV-1-exposed uninfected individuals inhibit HIV-1 transcytosis across human epithelial cells. J Immunol 2000; 165 (09) 5170-5176
164 Dunkelberger JR, Song WC. Complement and its role in innate and adaptive immune responses. Cell Res 2010; 20 (01) 34-50
165 Kanda N, Tamaki K. Estrogen enhances immunoglobulin production by human PBMCs. J Allergy Clin Immunol 1999; 103 (2, Pt 1): 282-288
166 So NSY, Ostrowski MA, Gray-Owen SD. Vigorous response of human innate functioning IgM memory B cells upon infection by Neisseria gonorrhoeae . J Immunol 2012; 188 (08) 4008-4022
167 Rodriguez-Garcia M, Patel MV, Shen Z, Wira CR. The impact of aging on innate and adaptive immunity in the human female genital tract. Aging Cell 2021; 20 (05) e13361
168 Mestecky J, Fultz PN. Mucosal immune system of the human genital tract. J Infect Dis 1999; 179 (Suppl. 03) S470-S474
169 Chan D, Bennett PR, Lee YS. et al. Microbial-driven preterm labour involves crosstalk between the innate and adaptive immune response. Nat Commun 2022; 13 (01) 975
170 Pudney J, Quayle AJ, Anderson DJ. Immunological microenvironments in the human vagina and cervix: mediators of cellular immunity are concentrated in the cervical transformation zone. Biol Reprod 2005; 73 (06) 1253-1263
171 Klemola T. Immunohistochemical findings in the intestine of IgA-deficient persons: number of intraepithelial T lymphocytes is increased. J Pediatr Gastroenterol Nutr 1988; 7 (04) 537-543
172 Bunker JJ, Flynn TM, Koval JC. et al. Innate and adaptive humoral responses coat distinct commensal bacteria with immunoglobulin A. Immunity 2015; 43 (03) 541-553
173 Bunker JJ, Bendelac A. IgA responses to microbiota. Immunity 2018; 49 (02) 211-224
174 Dalal SR, Chang EB. The microbial basis of inflammatory bowel diseases. J Clin Invest 2014; 124 (10) 4190-4196
175 Kanai T, Kawamura T, Dohi T. et al. TH1/TH2-mediated colitis induced by adoptive transfer of CD4+CD45RB high T lymphocytes into nude mice. Inflamm Bowel Dis 2006; 12 (02) 89-99
176 Uo M, Hisamatsu T, Miyoshi J. et al. Mucosal CXCR4+ IgG plasma cells contribute to the pathogenesis of human ulcerative colitis through FcγR-mediated CD14 macrophage activation. Gut 2013; 62 (12) 1734-1744
177 Chan Y, Fornace K, Wu L. et al. Determining seropositivity—a review of approaches to define population seroprevalence when using multiplex bead assays to assess burden of tropical diseases. PLoS Negl Trop Dis 2021; 15 (06) e0009457
178 Dowlatshahi S, Shabani E, Abdekhodaie MJ. Serological assays and host antibody detection in coronavirus-related disease diagnosis. Arch Virol 2021; 166 (03) 715-731
179 Durazzi F, Sala C, Castellani G, Manfreda G, Remondini D, De Cesare A. Comparison between 16S rRNA and shotgun sequencing data for the taxonomic characterization of the gut microbiota. Sci Rep 2021; 11 (01) 3030
180 López-Aladid R, Fernández-Barat L, Alcaraz-Serrano V. et al. Determining the most accurate 16S rRNA hypervariable region for taxonomic identification from respiratory samples. Sci Rep 2023; 13 (01) 3974
181 Brown EL, Essigmann HT, Hoffman KL. et al. Impact of diabetes on the gut and salivary IgA microbiomes. Infect Immun 2020; 88 (12) 1-12
182 Jackson MA, Pearson C, Ilott NE. et al. Accurate identification and quantification of commensal microbiota bound by host immunoglobulins. Microbiome 2021; 9 (01) 33
183 Morton JT, Marotz C, Washburne A. et al. Establishing microbial composition measurement standards with reference frames. Nat Commun 2019; 10 (01) 2719
184 Palm NW, de Zoete MR, Cullen TW. et al. Immunoglobulin A coating identifies colitogenic bacteria in inflammatory bowel disease. Cell 2014; 158 (05) 1000-1010
185 Silverman MA, Green JL. Insight into host-microbe interactions using microbial flow cytometry coupled to next-generation sequencing. J Pediatric Infect Dis Soc 2021; 10 (Suppl. 04) S106-S111
186 Bos NA, Bun JCAM, Popma SH. et al. Monoclonal immunoglobulin A derived from peritoneal B cells is encoded by both germ line and somatically mutated VH genes and is reactive with commensal bacteria. Infect Immun 1996; 64 (02) 616-623
187 Kroese FGM, de Waard R, Bos NA. B-1 cells and their reactivity with the murine intestinal microflora. Semin Immunol 1996; 8 (01) 11-18
188 van der Waaij LA, Mesander G, Limburg PC, van der Waaij D. Direct flow cytometry of anaerobic bacteria in human feces. Cytometry 1994; 16 (03) 270-279
189 Moor K, Fadlallah J, Toska A. et al. Analysis of bacterial-surface-specific antibodies in body fluids using bacterial flow cytometry. Nat Protoc 2016; 11 (08) 1531-1553
190 Conrey PE, Denu L, O'Boyle KC. et al. IgA deficiency destabilizes homeostasis toward intestinal microbes and increases systemic immune dysregulation. Sci Immunol 2023; 8 (83) eade2335
191 Wilmore JR, Gaudette BT, Gomez Atria D. et al. Commensal microbes induce serum IgA responses that protect against polymicrobial sepsis. Cell Host Microbe 2018; 23 (03) 302-311.e3
192 Kan B, Razzaghian HR, Lavoie PM. An immunological perspective on neonatal sepsis. Trends Mol Med 2016; 22 (04) 290-302
193 Emerson JB, Adams RI, Román CMB. et al. Schrödinger's microbes: tools for distinguishing the living from the dead in microbial ecosystems. Microbiome 2017; 5 (01) 86
194 Lambrecht J, Schattenberg F, Harms H, Mueller S. Characterizing microbiome dynamics - flow cytometry based workflows from pure cultures to natural communities. J Vis Exp 2018; 2018 (137) 58033
195 Koch MA, Reiner GL, Lugo KA. et al. Maternal IgG and IgA antibodies dampen mucosal T helper cell responses in early life. Cell 2016; 165 (04) 827-841
196 Doron I, Leonardi I, Li XV. et al. Human gut mycobiota tune immunity via CARD9-dependent induction of anti-fungal IgG antibodies. Cell 2021; 184 (04) 1017-1031.e14
197 Kau AL, Planer JD, Liu J. et al. Functional characterization of IgA-targeted bacterial taxa from undernourished Malawian children that produce diet-dependent enteropathy. Sci Transl Med 2015; 7 (276) 276ra24
198 Tiu CK, Zhu F, Wang LF, de Alwis R. Phage ImmunoPrecipitation Sequencing (PhIP-Seq): the promise of high throughput serology. Pathogens 2022; 11 (05) 568
199 Lingasamy P, Tobi A, Haugas M. et al. Bi-specific tenascin-C and fibronectin targeted peptide for solid tumor delivery. Biomaterials 2019; 219: 119373
200 Lingasamy P. Development of Multitargeted Tumor Penetrating Peptides. University of Tartu; 2020 http://hdl.handle.net/10062/70738
201 Larman HB, Zhao Z, Laserson U. et al. Autoantigen discovery with a synthetic human peptidome. Nat Biotechnol 2011; 29 (06) 535-541
202 Mohan D, Wansley DL, Sie BM. et al. PhIP-Seq characterization of serum antibodies using oligonucleotide-encoded peptidomes. Nat Protoc 2018; 13 (09) 1958-1978
203 Larman HB, Laserson U, Querol L. et al. PhIP-Seq characterization of autoantibodies from patients with multiple sclerosis, type 1 diabetes and rheumatoid arthritis. J Autoimmun 2013; 43: 1-9
204 Román-Meléndez GD, Monaco DR, Montagne JM. et al. Citrullination of a phage-displayed human peptidome library reveals the fine specificities of rheumatoid arthritis-associated autoantibodies. EBioMedicine 2021; 71: 103506
205 Xu GJ, Kula T, Xu Q. et al. Viral immunology. Comprehensive serological profiling of human populations using a synthetic human virome. Science 2015; 348 (6239) aaa0698
206 Cantarelli C, Jarque M, Angeletti A. et al. A comprehensive phenotypic and functional immune analysis unravels circulating anti-phospholipase A2 receptor antibody secreting cells in membranous nephropathy patients. Kidney Int Rep 2020; 5 (10) 1764-1776
207 Angkeow JW, Monaco DR, Chen A. et al. Phage display of environmental protein toxins and virulence factors reveals the prevalence, persistence, and genetics of antibody responses. Immunity 2022; 55 (06) 1051-1066.e4
208 Venkataraman T, Swaminathan H, Arze CA. et al. Comprehensive profiling of antibody responses to the human anellome using programmable phage display. Cell Rep 2022; 41 (12) 111754
209 Vogl T, Klompus S, Leviatan S. et al. Population-wide diversity and stability of serum antibody epitope repertoires against human microbiota. Nat Med 2021; 27 (08) 1442-1450
210 Leviatan S, Vogl T, Klompus S, Kalka IN, Weinberger A, Segal E. Allergenic food protein consumption is associated with systemic IgG antibody responses in non-allergic individuals. Immunity 2022; 55 (12) 2454-2469.e6
211 Andreu-Sánchez S, Bourgonje AR, Vogl T. et al; Lifelines Cohort Study. Phage display sequencing reveals that genetic, environmental, and intrinsic factors influence variation of human antibody epitope repertoire. Immunity 2023; 56 (06) 1376-1392.e8
212 Bourgonje AR, Andreu-Sánchez S, Vogl T. et al. Phage-display immunoprecipitation sequencing of the antibody epitope repertoire in inflammatory bowel disease reveals distinct antibody signatures. Immunity 2023; 56 (06) 1393-1409.e6